Investors Buy High Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw unusually large options trading activity on Wednesday. Stock investors purchased 1,885 put options on the stock. This represents an increase of 1,101% compared to the average volume of 157 put options.

Evelo Biosciences Stock Performance

The firm has a 50 day simple moving average of $0.03 and a 200-day simple moving average of $0.04. Evelo Biosciences has a twelve month low of $0.00 and a twelve month high of $7.69. The company has a market cap of $2,000.00, a price-to-earnings ratio of 0.00 and a beta of 1.58.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.